Skip to main content

National Human Genome Research Institute Archives

Study to search EHR for undiagnosed genetic diseases

Oct. 13, 2022—A team at Vanderbilt University Medical Center will explore computational solutions to help address the problem of missed or delayed diagnosis for patients with rare genetic diseases.

Read more


Study explores clinical uses for polygenic risk scores

Jul. 14, 2022—Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores.

Read more


VUMC joins national effort to improve disease prediction in diverse populations

Jun. 16, 2021—Vanderbilt University Medical Center will participate in a new federal initiative aimed at improving the use of polygenic risk scores (PRS) to predict complex diseases in diverse populations.

Read more


Center for Genetic Privacy lands major grant renewal

Sep. 17, 2020—The National Human Genome Research Institute (NHGRI) has awarded a four-year, $4 million grant renewal to Vanderbilt University Medical Center’s Center for Genetic Privacy and Identity in Community Settings (GetPreCiSe).

Read more


Award supports integration of genomic data, electronic health records

Sep. 10, 2020—Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.

Read more


VUMC-led network to focus on polygenic risk for common diseases

Jul. 1, 2020—With the aid of a $75 million, five-year grant renewal, the Electronic Medical Records and Genomics Network (eMERGE) will venture beyond its current focus on monogenic disease to scoring research participants’ relative risk for complex heritable diseases such as cardiovascular disease, chronic kidney disease and type 2 diabetes.

Read more


Gamazon receives NIH Genomic Innovator Award

Sep. 19, 2019—VUMC's Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more